Actual Medicinal Product (AMP) Budesonide 3mg gastro-resistant modified-release capsules (Xiromed)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Light sensitive medicine - store in light resistant container. Moisture sensitive medicine - store in airtight (sealed) MCA. Original packaging may contain desiccant. Manufacturer recommends storing in original container.

Provenance

This recommendation is based on the products Entocort CR 3mg capsules and Budesonide CR 3mg capsules (Tillots Pharma UK Ltd).

Generic
Budesonide
Formulation
Budesonide 3mg gastro-resistant modified-release capsules
  • Budesonide
    • Budesonide 3mg gastro-resistant modified-release capsules

      • Budesonide 3mg gastro-resistant modified-release capsules (Xiromed)